Recruiting Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC) NCT05037279 Conditions Bladder Cancer, Bladder Cancer Recurrent, Disease Attributes, +18 more Locations Site 05 — Vancouver, British Columbia, Canada Site 04 — Kingston, Ontario, Canada Site 01 — Toronto, Ontario, Canada Site 02 — Toronto, Ontario, Canada View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. NCT06167356 Conditions Bladder Cancer, Bladder Cancer Recurrent, Bladder Cancer Stage I, With Cancer in Situ, +22 more Locations IRCCS Ospedale San Raffaele — Milan, MI, Italy View Trial Details
Completed The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression NCT04617743 Conditions Bladder Cancer Recurrent, Carcinoma, Disease Attributes, +19 more Locations Health Sciences University, Dıskapi Yildirim Beyazit Training and Research Hospital — Ankara, Turkey (Türkiye) Istanbul Medeniyet University — Istanbul, Turkey (Türkiye) Health Sciences University, Tepecik Training and Research Hospital — Izmir, Turkey (Türkiye) View Trial Details